A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
Clinical trial NCT05051904 · COMPLETED
Trial details
- NCT number
- NCT05051904
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-17
- Primary completion
- 2022-07-29
- Enrollment
- 39357
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.